1. Time for a change to clozapine haematological monitoring.
- Author
-
Cheng, Adrian, Buten, Sara, and Large, Matthew
- Subjects
CLOZAPINE ,NEUTROPENIA ,AGRANULOCYTOSIS ,NEUTROPHILS ,PATHOLOGICAL physiology - Abstract
Objectives: This paper critiques the haematological monitoring guidelines for clozapine. It describes the history of clozapine, as well as the pathophysiology and epidemiology of clozapine-induced neutropenia (CIN) and agranulocytosis (CIA). The paper appraises the extant literature on mandatory clozapine haematological monitoring. Conclusion: Contemporary Australian protocols for clozapine haematological monitoring are not consistent with the current evidence base. CIN and CIA are rare occurrences, and the associated risk of death is low. Potential modifications to existing guidelines include changing neutrophil thresholds for patients with benign ethnic neutropenia and reducing the frequency or removing haematological monitoring after two years of clozapine treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF